EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cost‐effectiveness analysis of alternative screening strategies for the detection of cervical cancer among women in rural areas of Western Kenya

Christopher Lobin iD, Elkanah Omenge Orang'o, Edwin Were, Kapten Muthoka, Kavita Singh, Manuela De Allegri, Konrad Obermann, Magnus von Knebel Doeberitz, Hermann Bussmann

International Journal of Cancer · 2024-10 · 155 (7) · 1257-1267

DOI: 10.1002/ijc.35036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, online erschienen am 27.05.2024. Verfasst von Christopher Lobin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany. Hauptthemen laut MEDLINE: Cost-Effectiveness Analysis, Early Detection of Cancer, Papillomavirus Infections, Rural Population. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Ladenburg Foundation New York, Fogarty International Centre, National Institutes of Health (NIH), United States.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While the incidence of cervical cancer has dropped in high‐income countries due to organized cytology‐based screening programs, it remains the leading cause of cancer death among women in Eastern Africa. Therefore, the World Health Organization (WHO) now urges providers to transition from widely prevalent but low‐performance visual inspection with acetic acid (VIA) screening to primary human papillomavirus (HPV) DNA testing. Due to high HPV prevalence, effective triage tests are needed to identify those lesions likely to progress and so avoid over‐treatment. To identify the optimal cost‐effective strategy, we compared the VIA screen‐and‐treat approach to primary HPV DNA testing with p16/Ki67 dual‐stain cytology or VIA as triage. We used a Markov model to calculate the budget impact of each strategy with incremental quality‐adjusted life years and incremental cost‐effectiveness ratios (ICER) as the main outcome. Deterministic cost‐effectiveness analyses show that the screen‐and‐treat approach is highly cost‐effective (ICER 2469 Int$), while screen, triage, and treat with dual staining is the most effective with favorable ICER than triage with VIA (ICER 9943 Int$ compared with 13,177 Int$). One‐way sensitivity analyses show that the results are most sensitive to discounting, VIA performance, and test prices. In the probabilistic sensitivity analyses, the triage option using dual stain is the optimal choice above a willingness to pay threshold of 7115 Int$ being cost‐effective as per WHO standards. The result of our analysis favors the use of dual staining over VIA as triage in HPV‐positive women and portends future opportunities and necessary research to improve the coverage and acceptability of cervical cancer screening programs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Effectiveness AnalysisEarly Detection of CancerPapillomavirus InfectionsRural PopulationUterine Cervical NeoplasmsAdultFemaleHumansMiddle AgedAcetic AcidKenyaMarkov ChainsMass ScreeningQuality-Adjusted Life Years

Stichwörter der Autor:innen

HPV DNA testcervical cancer screeningcost‐effectiveness analysesdual stainingvisual inspection with acetic acid

Substanzen

Acetic Acid

Autor:innen und Institutionen

  • Applied Tumor Biology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Department of Reproductive Health, School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya.
  • Department of Obstetrics and Gynaecology, Aga Khan University, Nairobi, Kenya.
  • Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Germany.
  • Public Health Foundation of India, New Delhi, India.
  • CPD Center for Preventive Medicine and Digital Health, Ruprecht-Karls University Heidelberg, Germany.

ORCID-Profile: Christopher Lobin

Förderung

  • Bundesministerium für Bildung und Forschung
  • Ladenburg Foundation New York
  • Fogarty International Centre, National Institutes of Health (NIH), United States
  • Medical Data Scientist Fellowship, Medical Faculty Heidelberg, University of Heidelberg, Germany

Zitieren

APA

Lobin, C., Orang'o, E. O., Were, E., Muthoka, K., Singh, K., De Allegri, M., Obermann, K., von Knebel Doeberitz, M., & Bussmann, H. (2024). Cost‐effectiveness analysis of alternative screening strategies for the detection of cervical cancer among women in rural areas of Western Kenya. International Journal of Cancer, 155(7), 1257-1267. https://doi.org/10.1002/ijc.35036

Vancouver

Lobin C, Orang'o EO, Were E, Muthoka K, Singh K, De Allegri M, et al. Cost‐effectiveness analysis of alternative screening strategies for the detection of cervical cancer among women in rural areas of Western Kenya. International Journal of Cancer. 2024;155(7):1257-1267. doi:10.1002/ijc.35036

BibTeX
@article{Lobin2024,
  author = {Lobin, Christopher and Orang'o, Elkanah Omenge and Were, Edwin and Muthoka, Kapten and Singh, Kavita and De Allegri, Manuela and Obermann, Konrad and von Knebel Doeberitz, Magnus and Bussmann, Hermann},
  title = {Cost‐effectiveness analysis of alternative screening strategies for the detection of cervical cancer among women in rural areas of Western Kenya},
  journal = {International Journal of Cancer},
  year = {2024},
  volume = {155},
  number = {7},
  pages = {1257--1267},
  doi = {10.1002/ijc.35036}
}
Kostenlos starten →